Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.

Jguirim-Souissi I, Jelassi A, Slimani A, Addad F, Hassine M, Hamda KB, Najah M, Maatouk F, Rouis M, Slimane MN.

Coron Artery Dis. 2011;22(6):388-93. doi: 10.1097/MCA.0b013e3283478d40.

PMID:
21606841
2.

Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.

Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I.

Coron Artery Dis. 2009 Sep;20(6):383-6. doi: 10.1097/MCA.0b013e32832fa9cf.

PMID:
19620856
3.

Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the risk of ischemic stroke in a Tunisian population.

Chehaibi K, Hrira MY, Nouira S, Maatouk F, Ben Hamda K, Slimane MN.

J Neurol Sci. 2014 Jul 15;342(1-2):107-13. doi: 10.1016/j.jns.2014.04.036. Epub 2014 May 2.

PMID:
24834994
4.

An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.

Ashokkumar M, Anbarasan C, Saibabu R, Kuram S, Raman SC, Cherian KM.

Thromb Res. 2011 Oct;128(4):e49-53. doi: 10.1016/j.thromres.2011.05.026. Epub 2011 Jul 16.

PMID:
21762961
5.

Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.

Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.

Carcinogenesis. 2004 Dec;25(12):2379-84. Epub 2004 Aug 19.

PMID:
15319295
6.

Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.

Wu TC, Leu HB, Lin WT, Lin CP, Lin SJ, Chen JW.

Eur J Clin Invest. 2005 Sep;35(9):537-45.

PMID:
16128859
7.

Inflammatory cytokine gene variants in coronary artery disease patients in Greece.

Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, Cokkinos DV.

Coron Artery Dis. 2008 Dec;19(8):575-82. doi: 10.1097/MCA.0b013e32831286e8.

PMID:
19005292
8.

Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.

Xu X, Wang L, Xu C, Zhang P, Yong F, Liu H, Wang J, Shi Y.

Coron Artery Dis. 2013 Jun;24(4):259-65. doi: 10.1097/MCA.0b013e32835ea3af.

PMID:
23377317
9.

Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.

Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I.

Clin Chim Acta. 2012 Jan 18;413(1-2):113-20. doi: 10.1016/j.cca.2011.09.004. Epub 2011 Sep 22.

PMID:
21963461
10.

Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population.

Gao J, Shao Y, Lai W, Ren H, Xu D.

J Hum Genet. 2010 Oct;55(10):668-75. doi: 10.1038/jhg.2010.85. Epub 2010 Jul 29.

PMID:
20668462
11.

Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression.

Sun T, Gao Y, Tan W, Ma S, Zhang X, Wang Y, Zhang Q, Guo Y, Zhao D, Zeng C, Lin D.

Clin Cancer Res. 2006 Dec 1;12(23):7009-17.

12.

Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21.

Gioli-Pereira L, Santos PC, Ferreira NE, Hueb WA, Krieger JE, Pereira AC.

BMC Cardiovasc Disord. 2012 Aug 2;12:61. doi: 10.1186/1471-2261-12-61.

13.

Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.

Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I.

Med Sci Monit. 2008 Oct;14(10):CR536-42.

PMID:
18830194
14.

Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease.

Schettert IT, Pereira AC, Lopes NH, Hueb WA, Krieger JE.

Thromb Res. 2006;118(6):679-83. Epub 2006 Jan 6.

PMID:
16405973
15.

A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.

Vasků A, Goldbergová M, Izakovicová Hollá L, Sisková L, Groch L, Beránek M, Tschöplová S, Znojil V, Vácha J.

Matrix Biol. 2004 Jan;22(7):585-91.

PMID:
14996438
16.

Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.

Lin CC, Yang WC, Chung MY, Lee PC.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1805-14. doi: 10.2215/CJN.01500210. Epub 2010 Jul 8.

17.

Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction.

Pearce E, Tregouet DA, Samnegård A, Morgan AR, Cox C, Hamsten A, Eriksson P, Ye S.

Circ Res. 2005 Nov 11;97(10):1070-6. Epub 2005 Oct 6.

PMID:
16210545
18.

Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.

Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC.

Carcinogenesis. 2006 May;27(5):1024-9. Epub 2005 Nov 25.

PMID:
16311244
19.

Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.

Park KS, Min Y, Park SR, Kim EH, Lee DJ, Bang D, Lee ES.

Tissue Antigens. 2012 May;79(5):333-9. doi: 10.1111/j.1399-0039.2012.01863.x. Epub 2012 Mar 19.

PMID:
22428754
20.

Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer.

Weng CJ, Chen MK, Lin CW, Chung TT, Yang SF.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S319-27. doi: 10.1245/s10434-011-1736-x. Epub 2011 Apr 22.

PMID:
21512861

Supplemental Content

Support Center